Reduced uterine perfusion initiated in late gestation in the rat results in intrauterine growth restriction (IUGR) and development of hypertension by 4 weeks of age. We hypothesize that the renin angiotensin system (RAS), a regulatory system important in the long term control of blood pressure, may be programmed by placental insufficiency and may contribute to the etiology of IUGR hypertension. We previously reported that RAS blockade abolished hypertension in adult IUGR offspring; however, the mechanisms responsible for the early phase of hypertension are unresolved. Therefore, the purpose of this study was to examine RAS involvement in early programmed hypertension and to determine whether temporal changes in RAS expression are observed in IUGR offspring. Renal renin and angiotensinogen mRNA expression were significantly decreased at birth (80 and 60 percent, respectively); plasma and renal RAS did not differ in conjunction with hypertension (mean increase of 14 mmHg) in young IUGR offspring; however, hypertension (mean increase of 22 mmHg) in adult IUGR offspring was associated with marked increases in renal ACE activity (122%) and renal renin and angiotensinogen mRNA (7-fold and 7.4-fold, respectively), but no change in renal angiotensin II or angiotensin type 1 receptor. ACE inhibition (enalapril, 10 mg/kg/day, administered from 2 to 4 weeks of age) abolished hypertension in IUGR at 4 weeks of age (decrease of 15 mmHg, respectively) with no significant depressor effect in control offspring. Therefore, temporal alterations in renal RAS are observed in IUGR offspring and may play a key role in the etiology of IUGR hypertension.
INTRODUCTION
Epidemiological and experimental studies provide strong evidence to suggest cardiovascular disease and hypertension are programmed by exposure to adverse conditions in utero (1, 6, 11, 12, 13, 17, 30, 51, 55) . The inverse relationship observed in epidemiological studies between birth weight and blood pressure suggests that factors involved in prenatal development, which affect fetal growth, are responsible for the in utero programming of arterial blood pressure (6, 7, 25, 31) . Mechanisms involved in the pre-natal programming of hypertension are unclear.
However, animal studies suggest a role for the kidneys (1, 2, 30, 51, 55, 54, 56) in the pathogenesis of pre-natal programmed hypertension with inclusion of the renin angiotensin system (RAS) (30, 44, 51, 55) .
Numerous investigators have examined the role of the RAS in models of prenatal programming induced by protein restriction during gestation in the rat (33, 34, 40, 43, 45, 48, 51, 52, 55) and pre-natal exposure to glucocorticoids (XX). Suppression of the RAS observed at birth (51, 55) may lead to permanent structural changes associated with the pathogenesis of hypertension in offspring from protein restricted dams (55) . Up-regulation of the renal angiotensin type 1 receptor (AT 1 R) following late gestational protein restriction is observed as early as 4 weeks of age by some investigators (30, 33, 51) , but not others (35) , and characterization of the renal RAS including AT 1 R has not yet been determined in the adult hypertensive offspring. Marked increases in plasma renin activity (PRA) following late gestational protein restriction are also observed as early as 4 weeks of age by some investigators (30) , but not by other investigators who observe suppression of PRA at 4 weeks of age with a gradual increase leading to inappropriate activation at 6 months of age (30) . Thus, temporal alterations in the RAS are reported by investigators utilizing similar models of pre-natal Page 3 of 33 programming induced by gestational protein restriction (30, 33, 48, 51, 52, 55) . More importantly, the critical role of the RAS in the etiology of hypertension programmed by protocols of in utero protein restriction is indicated by RAS blockade studies (24, 48) .
Furthermore, alterations in the RAS may also be responsible for marked increases in blood pressure programmed by pre-natal exposure to glucocorticoids indicating fetal insults lead to similar pathways of programmed hypertension (XX).
Our laboratory utilizes a model of prenatal programmed hypertension initiated by reduced uterine perfusion that may better reflect the patho-physiological induction of intrauterine growth restriction (IUGR) in humans in the Western world. IUGR induced by placental insufficiency is associated with development of hypertension in male growth-restricted offspring (1, 40) . We previously reported that ACE inhibition abolishes hypertension in adult male growth-restricted offspring (40) suggesting that the RAS plays a critical role in the maintenance of established hypertension in this model of IUGR. Thus, the purpose of this study was to determine whether temporal alterations in the RAS are present in male growth restricted offspring from reduced uterine perfusion dams, and to determine the quantitative importance of the RAS in the early phase of programmed hypertension in male growth restricted offspring. Products, Madison, WI). At day 14 of gestation, a midline abdominal incision was done and the lower abdominal aorta was isolated and a silver clip (0.203 mm ID) was placed around the aorta above the iliac bifurcation. Since compensation of blood flow to the placenta occurs through an adaptive increase in ovarian blood flow, flow to both the right and left ovarian arteries that supply the uterus was reduced using silver clips (0.100 mm ID). Pregnant rats used for the control group were not exposed to surgical procedures. Based on previous observations, no differences have been observed between offspring from pregnant rats undergoing a sham operation and offspring from pregnant rats not exposed to surgical procedures. (Alexander BT, unpublished data, 2003) .
MATERIALS AND METHODS.
Acute arterial pressure measurements in conscious rats. Mean arterial pressure (MAP) was measured acutely as previously described (1) . Briefly, rats were anesthetized with isoflurane as described above and surgically instrumented with a carotid arterial catheter (PE 50 tubing).
Following 3 days of recovery, rats acclimated to restraint were placed in modified restraining cages with arterial pressure monitored with a pressure transducer connected to a data acquisition kit (DATAQ Instruments, Inc., Akron, OH) and computer for continuous recording. All animals were acclimated to restraint for two hours prior to a one-hour equilibration period followed by 2-twenty minute pressure determinations. All pressure measurements were made during mid morning hours.
Measure of plasma renin activity. Renin activity in plasma was measured by radioimmunoassay (RIA) using a modification of Haber and associates (22) Isolation of total cellular RNA and Real-time PCR. Total RNA was utilized for quantitation of the mRNA message by Real-Time PCR. Kidneys were removed, quick frozen in liquid nitrogen, and stored at -80 0 C. Each kidney was first ground using a liquid nitrogen chilled mortar and pestle and total RNA was isolated using a guanidine thicyanide, acid phenol:chloroform procedure (ToTALLY RNA kit, Ambion, Austin, TX). Total RNA concentration and purity were determined spectrophotometrically using A260 and A260/280 ratio, respectively. Total RNA integrity was checked using 1% agarose gel electrophoresis. All RNA isolates were DNA free by treatment with DNAse (DNA-free kit, Ambion, Austin, TX). 2 µg of total RNA were reverse transcribed using a modified MMLV-derived reverse transcriptase and a unique blend of oligo (dT) and random hexamer primers (iScript TM cDNA Synthesis Kit, BIO-RAD). 1µl of the resulting cDNA was amplified by real-time PCR using SYBR Green (iQ TM SYBR Green Supermix, BIO-RAD) as fluorophore in an iCycler real-time thermal cycler (BIO-RAD).
Specific pairs of primers was used for each gene amplification. PCR conditions were optimized for each pair of primers. DNA sequencing of the fragment amplified confirmed specificity of the PCR products.
Renin ( Radioimmunoassay for angiotensin II. Briefly, frozen kidneys were quickly weighed and quick frozen in liquid nitrogen. For analysis they were homogenized, and extracted using SepPak columns. Solvent was evaporated and recovery of radiolabeled angiotensin added to the samples was determined during the extraction. Recovery of radiolabeled peptide was corrected for recovery. Ang II was measured using the Alpco Diagnostics kit (Windham, NH).
Radioligand autoradiography for ANG II receptors and ACE. Quantitative autoradiography was utilized to determine renal AT 1 R, AT 2 R, and ACE binding from whole kidneys as previously described (5, 28, 29) . Briefly, kidneys were snap-frozen in liquid nitrogen, cut sagitally into sequential 20-µm thick frozen sections within 1 week of harvest, thaw-mounted onto gelatin-coated slides, air-dried, and stored at -20 C. Within one week of sectioning, the sections were thawed and the autoradiography procedure was carried out. For AT 1 and AT 2 receptor autoradiography, sections were pre-incubated for 30 minutes at room temperature in isotonic buffer (50 mM NaPO 4 , 150 mM NaCl, 5 mM EDTA, 0.1 mM bacitracin, pH 7.1-7.2).
Consecutive sections were incubated for 2 hours in isotonic-buffer containing 0. MK-422 for 1 hour at room temperature for determination of ACE as previously described (4, 24) . Following radioligand incubation, sections were rinsed, dried, and exposed to Kodak Biomax MR1 X-ray film, at -20°C for ~36 hours. A standard slide with calibrated concentrations ranging from 1 to 600 nCi/mg 125 I (Microscales, GE Healthcare Biosciences, Piscataway, NJ) was included in each cassette. The film was developed using an automated film processor. We next examined whether temporal alterations in the RAS were observed in this model of pre-natal programmed hypertension induced by placental insufficiency. RAS components are highly expressed in the developing kidney and play a role in mediating proper nephrogenesis (20, 57) . AT 1 R blockade during the nephrogenic period in the rat leads to a reduction in nephron number and development of hypertension (57) suggested by studies in transgenic animals, intrarenal ANG II can contribute to development of hypertension despite the absence of an increase in the peripheral RAS (14) . Therefore, the intra-renal RAS, not the peripheral RAS, may contribute to the etiology of hypertension in growthrestricted offspring from reduced uterine perfusion dams.
All components of the RAS are present in the kidney (19) . Since RAS blockade abolishes hypertension in adult growth-restricted offspring suggesting RAS involvement (40), we characterized the renal RAS in growth-restricted offspring to determine if alterations were present in this model of IUGR-induced hypertension. Renal renin and angiotensinogen mRNA expression were no longer suppressed at 6 weeks of age as previously observed at birth, and
were significantly elevated at 16 weeks of age in the cortex of adult growth-restricted offspring relative to control offspring. A marked increase in renal ACE activity was also observed at 16
weeks of age in adult growth-restricted offspring. However, ACE and AT 1 R mRNA expression did not differ upon comparison of adult growth-restricted offspring to control. Quantitative autoradiography also showed no difference between ACE and AT 1 R expression in the kidneys of adult growth-restricted offspring relative to control. Although renal ACE activity was increased in adult growth restricted offspring at 16 weeks of age in conjunction with increased levels of renin substrate, ANG II formation was not increased.
Angiotensinogen of hepatic origin can serve as the substrate for generation of intra-renal ANG II; however, angiotensinogen is also present within the proximal tubule (27) and can be stimulated by testosterone (39) . We previously reported that plasma testosterone levels are elevated two-fold in adult male growth restricted offspring (40) . Regulation of renal angiotensinogen by testosterone can occur in a dose dependent fashion (16) suggesting that elevated testosterone in adult male growth restricted offspring may serve as the stimulus for enhanced renal angiotensinogen observed in this model of IUGR hypertension. Enhanced renal angiotensinogen levels can lead to activation of the RAS and hypertension (26) and we have demonstrated the importance of the RAS in mediating hypertension in adult male growth restricted offspring (40) . However, despite enhanced intra-renal angiotensinogen, increased intra-renal ANG II was not observed in conjunction with established hypertension in adult male IUGR. Discrepancies in intra-renal angiotensinogen and ANG II are also observed in the Dahl salt-sensitive (28) and Zucker Diabetic rat (50) , yet the importance of ANG II in these experimental models is demonstrated by the renoprotective effects mediated via AT1 receptor blockade (33, 39, 50) . Therefore, the intrarenal RAS, independent of the peripheral RAS, may Animal studies provide evidence suggesting that insults during gestation result in structural and physiological alterations leading to hypertension associated with permanent changes in the regulatory systems involved in the long-term control of arterial pressure.
Alterations in intra-renal RAS contribute to the etiology of hypertension in offspring from reduced uterine perfusion dams, an observation similar to that observed by other investigators using models of gestational protein restriction and pre-natal glucocorticoid exposure. The pathogenesis of hypertension is multifactorial; and although insight provided by different animal models highlights the complexities involved in the developmental origins of adult disease, the presence of common mechanistic pathways is suggested.
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